- Home
- HSCS vs IBG Comparison
HSCS vs IBG Comparison
Compare HSCS & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | IBG |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 8.8M |
| IPO Year | 2022 | 2024 |
Fundamental Metrics
Financial Performance| Metric | HSCS | IBG |
|---|---|---|
| Price | $3.52 | $0.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.20 | N/A |
| AVG Volume (30 Days) | 55.7K | ★ 204.4K |
| Earning Date | 03-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,669.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $1.40 |
| 52 Week High | $6.47 | $9.85 |
Technical Indicators
Market Signals| Indicator | HSCS | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 21.98 |
| Support Level | $3.08 | $1.50 |
| Resistance Level | $3.70 | $1.75 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 77.33 | 10.20 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.